[EN] CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS ÉTHERS CYCLIQUES UTILES COMME INHIBITEURS DE KINASE
申请人:NOVARTIS AG
公开号:WO2012004217A1
公开(公告)日:2012-01-12
The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof, as further described herein. Also provided are formulations comprising compounds of formula I, and a method to use such compounds for treating a disease or condition mediated by Provirus Integration of Maloney Maloney Kinase (PIM Kinase), GSK3, PKC, KDR, PDGFRa, FGFR3, FLT3, or cABL.
本发明提供了一种公式(I)的化合物:以及在此进一步描述的药用可接受盐。还提供了包含公式I化合物的制剂,以及使用此类化合物治疗由莫伦莫伦激酶(Provirus Integration of Maloney Maloney Kinase, PIM Kinase)、GSK3、PKC、KDR、PDGFRa、FGFR3、FLT3或cABL介导的疾病或状况的方法。
CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS
申请人:Burger Matthew
公开号:US20130109682A1
公开(公告)日:2013-05-02
The present invention provides certain compounds of Formula (I):
and pharmaceutically acceptable salts thereof, as further described herein. Also provided are formulations comprising compounds of formula I, and a method to use such compounds for treating a disease or condition mediated by Provirus Integration of Maloney Kinase (PIM Kinase), GSK3, PKC, KDR, PDGFRa, FGFR3, FLT3, or cABL.
Wässrige Dispersionen von Carbonylgruppen aufweisenden Copolymerisaten, die Hydrazinderivate und Schwermetallionen enthalten
申请人:BASF Aktiengesellschaft
公开号:EP0003516A1
公开(公告)日:1979-08-22
Diese Erfindung betrifft wäßrige Dispersionen von Carbonylgruppenaufweisenden Copolymerisaten, die je Mol Carbonylgruppe 0,02 bis 1 Mol organische Hydrazinderivate mit mindestens 2 Hydrazinresten enthalten, und einen Gehalt von 0,0002 bis 0,02 Mol, bezogen auf 1 Mol der Hydrazinderivate, an Schwermetallionen aufweisen. .Die Dispersionen können vor allem als besonders leicht vernetzende Überzugs-, Imprägnier- oder Beschichtungsmittel, z. B. als Bindemittel für Faservliese sowie zum Veredeln von Leder verwendet werden.
A method for producing cyclopentadienes which comprises the step of cyclodehydration of an unsaturated carbonyl compound having a specific chemical structures in a vapor phase in the presence of a specific solid acid catalyst. The cyclopentadienes of the invention can be produced in a high yield from inexpensive starting materials through a simplified reaction process and are useful as intermediate compounds for organic synthesis.